Stock Track | Moderna Shares Soar 9.39% on Potential Buyout Talks

Stock Track

Oct 30

Moderna, Inc. (MRNA) stock is experiencing a significant surge, soaring 9.39% in Thursday's intraday trading session. This remarkable uptick comes on the heels of reports suggesting that the biotech company is in discussions about a potential buyout.

According to STAT News, Moderna is reportedly in talks with at least one large pharmaceutical company regarding a deal of substantial scope, which could include a complete buyout. This news has sparked investor interest, driving the stock price higher as market participants speculate on the potential for a lucrative acquisition.

While details of the potential deal remain undisclosed, the mere possibility of a buyout has injected renewed enthusiasm into Moderna's stock. The company, known for its mRNA technology and COVID-19 vaccine, has been facing challenges in the post-pandemic market. A potential acquisition by a larger drugmaker could provide Moderna with additional resources and market reach, potentially enhancing its long-term prospects in the competitive pharmaceutical industry.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1112454363"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1112454363\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1112454363?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-30 23:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1112454363","market":"nz","top_or_hot":-1,"title":"Stock Track | Moderna Shares Soar 9.39% on Potential Buyout Talks","media":"Stock Track","content":"<p>Moderna, Inc. (MRNA) stock is experiencing a significant surge, soaring 9.39% in Thursday's intraday trading session. This remarkable uptick comes on the heels of reports suggesting that the biotech company is in discussions about a potential buyout.</p>\n\n<p>According to STAT News, Moderna is reportedly in talks with at least one large pharmaceutical company regarding a deal of substantial scope, which could include a complete buyout. This news has sparked investor interest, driving the stock price higher as market participants speculate on the potential for a lucrative acquisition.</p>\n\n<p>While details of the potential deal remain undisclosed, the mere possibility of a buyout has injected renewed enthusiasm into Moderna's stock. The company, known for its mRNA technology and COVID-19 vaccine, has been facing challenges in the post-pandemic market. A potential acquisition by a larger drugmaker could provide Moderna with additional resources and market reach, potentially enhancing its long-term prospects in the competitive pharmaceutical industry.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Moderna Shares Soar 9.39% on Potential Buyout Talks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Moderna Shares Soar 9.39% on Potential Buyout Talks\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-10-30 23:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Moderna, Inc. (MRNA) stock is experiencing a significant surge, soaring 9.39% in Thursday's intraday trading session. This remarkable uptick comes on the heels of reports suggesting that the biotech company is in discussions about a potential buyout.</p>\n\n<p>According to STAT News, Moderna is reportedly in talks with at least one large pharmaceutical company regarding a deal of substantial scope, which could include a complete buyout. This news has sparked investor interest, driving the stock price higher as market participants speculate on the potential for a lucrative acquisition.</p>\n\n<p>While details of the potential deal remain undisclosed, the mere possibility of a buyout has injected renewed enthusiasm into Moderna's stock. The company, known for its mRNA technology and COVID-19 vaccine, has been facing challenges in the post-pandemic market. A potential acquisition by a larger drugmaker could provide Moderna with additional resources and market reach, potentially enhancing its long-term prospects in the competitive pharmaceutical industry.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"","article_id":"1112454363","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1112454363","pubTimestamp":1761838988,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Moderna, Inc. (MRNA) stock is experiencing a significant surge, soaring 9.39% in Thursday's intraday trading session. This remarkable uptick comes on the heels of reports suggesting that the biotech...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"股票追踪|Moderna股价因潜在收购谈判飙升9.39%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":1},"content_text":"Moderna, Inc. (MRNA) stock is experiencing a significant surge, soaring 9.39% in Thursday's intraday trading session. This remarkable uptick comes on the heels of reports suggesting that the biotech company is in discussions about a potential buyout.\nAccording to STAT News, Moderna is reportedly in talks with at least one large pharmaceutical company regarding a deal of substantial scope, which could include a complete buyout. This news has sparked investor interest, driving the stock price higher as market participants speculate on the potential for a lucrative acquisition.\nWhile details of the potential deal remain undisclosed, the mere possibility of a buyout has injected renewed enthusiasm into Moderna's stock. The company, known for its mRNA technology and COVID-19 vaccine, has been facing challenges in the post-pandemic market. A potential acquisition by a larger drugmaker could provide Moderna with additional resources and market reach, potentially enhancing its long-term prospects in the competitive pharmaceutical industry.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}